🔗 Share this article

An underground market for unlicensed weight-loss drugs is being driven by social media fitness personalities and sellers on communication apps, based on new investigations.

Investigational Treatment Acquiring Traction Online

The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing effects. Followers are urged to contact these profiles privately for source information, while also obtaining discount codes.

Active Trade on Messaging Platforms

Separately, a robust trade exists on messaging services, where groups with thousands of participants share comparison images, administration instructions and assertions of next-day British shipping. Sellers promote the drug there before directing customers to other platforms for purchases.

Understanding Retatrutide

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could help patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.

Medical Professionals Voice Worries

However, physicians and pharmacists have cautions that the sale of what remains an unlicensed drug in the UK is worrisome and could lead to individuals injecting substances of unknown origin.

Several professionals said the popularity for retatrutide could be linked to the rising cost of licensed weight loss treatments such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that must not be promoted or distributed for human use under the British medical regulations.

Some influencers attempt to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still violate pharmaceutical, marketing, and customer regulations, potentially leading to fines, prosecution or prison.

Platform Response and Material Removal

According to the social media company, the service has taken down problematic material and prohibited associated hashtags and search suggestions. The company said it was dedicated to keeping the platform safe and investing in strengthening enforcement strategies.

Online Trading Operations

Investigations also discovered communities with up to 9,000 participants marketing retatrutide using Telegram's integrated search feature, which operates like a online catalog. Typing “retatrutide” instantly displays channels with thousands of members, filled with photos of slimming results, positive reviews and detailed instructions for mixing or injecting at home.

Within minutes of joining one group, a vendor shared WhatsApp details, where the majority of purchases occur. The seller provided an guidebook and guaranteed delivery within 48 hours. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one inquired about body mass, health issues or past usage.

Item Details and Pricing

Inside these groups, messages display black plastic packages with Royal Mail labels, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at home with sterile water, or ready-to-use injectors usually priced at 160 pounds for 20 milligrams. When asked how long a injector should be used, sellers give contradictory responses varying between a several days to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for the messaging service said it actively monitored harmful content on its platform including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are administering materials they can’t verify. Although the research behind this drug is valid, these online products may not contain what they claim,” stated Jason Murphy, the head of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor connected the surge in demand to recent price rises for approved weight-loss medications such as Mounjaro. “With prices increasing, individuals are using social media. But fake treatments are highly dangerous. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she explained.

Her team has already seen individuals injured by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or communication platforms is taking chances with your well-being,” stated Wyllie. “These materials could be impure or incorrectly dosed.”

Producer Position

A representative from Eli Lilly said the substance was in phase 3 research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this point no one can market [it] for human use,” they said, adding that any product “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may expose patients to potentially serious health risks”.